Literature DB >> 1933636

Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction.

D Massel1, J B Gill, J A Cairns.   

Abstract

Potentially life-threatening immediate hypersensitivity reactions are extremely rare among patients treated with thrombolytic agents for suspected acute myocardial infarction. A patient who developed a severe reaction during an infusion of recombinant tissue-type plasminogen activator is described. Potential causal mechanisms for the reaction could be related either to nonmedicinal additives or complement activation. Implications for treatment in the setting of acute myocardial infarction are discussed.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1933636

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN： 0828-282X            Impact factor:   5.223


  3 in total

1.  Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke.

Authors:  M D Hill; P A Barber; J Takahashi; A M Demchuk; T E Feasby; A M Buchan
Journal:  CMAJ       Date:  2000-05-02       Impact factor: 8.262

2.  [Orolingual angioedema under systemic thrombolysis with rt-PA: an underestimated side effect].

Authors:  C Ottomeyer; C Sick; M G Hennerici; K Szabo
Journal:  Nervenarzt       Date:  2009-04       Impact factor: 1.214

3.  Life-Threatening Anaphylactoid Reaction in an Acute Ischemic Stroke Patient With Intravenous rt-PA Thrombolysis, Followed by Successful Intra-Arterial Thrombolysis.

Authors:  In-Serk Park; A-Hyun Cho; Seung-Jae Lee; Joong-Seok Kim; Kwang-Soo Lee; Yeong-In Kim
Journal:  J Clin Neurol       Date:  2008-03-20       Impact factor: 3.077
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.